UK Startup DNA Electronics Developing Handheld Device to Detect Genetic Risk for Drug AEs
February 25, 2009
UK Startup DNA Electronics Developing Handheld Device to Detect Genetic Risk for Drug AEs
Imperial College London and its spinout DNA Electronics have created a prototype for the so-called SNP Dr., which is being developed under a £1.2 million project that also includes Pfizer.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Monogram to Expand Oncology Franchise in '09 as '08 Revenues Rise 44 Percent
February 25, 2009 / Pharmacogenomics Reporter - PMC Asks FDA to Issue New Guidance Reflecting Rapidly Evolving Rx/Dx Co-development Landscape
December 16, 2009 / Pharmacogenomics Reporter - Q&A: Pfizer's Dx Division Head Discusses Pharma Giant's Focus on Personalized Medicine
September 9, 2009 / Pharmacogenomics Reporter - Genomic Health Updates Analysts on Companion Dx Pipeline, New Education Campaign
November 10, 2010 / Pharmacogenomics Reporter - Investment Bank Reports Advantage of CLIA Labs in Driving Adoption of OncotypeDX
April 8, 2009 / Pharmacogenomics Reporter